| Literature DB >> 7805312 |
A K Osumi1, R E Mclendon, R D Tien, H S Friedman, M Graham, B Hockenberger, E C Halperin, W J Oakes.
Abstract
Conventional treatment for medulloblastoma includes surgical resection followed by craniospinal irradiation, with the potential risk of subsequent radiotherapy-induced secondary neoplasms. We report a 23-year-old woman previously irradiated nine years earlier for a cerebellar medulloblastoma who developed a new enhancing lesion in the primary radiation field four weeks following completion of high dose chemotherapy with bone marrow transplantation for recurrent disease. Resection of this lesion revealed a low grade glioma with no evidence of recurrent medulloblastoma.Entities:
Mesh:
Year: 1994 PMID: 7805312
Source DB: PubMed Journal: Clin Neuropathol ISSN: 0722-5091 Impact factor: 1.368